Methylene blue. A possible treatment for manic depressive psychosis (1983)

Peer-Reviewed Study · Narsapur SL, Naylor GJ. · May 1983

Narsapur SL et al., 1983-05: Uncontrolled series of 19 manic-depressive patients who had failed to respond to standard therapies, given oral methylene blue; 14 were judged to show definite improvement and 3 with an uncertain diagnosis did not respond.

Of the 19 manic depressives who received oral methylene blue, 14 were judged to show definite improvement, 3 patients in whom the diagnosis was uncertain showed no beneficial response.

Narsapur SL et al., 1983-05: Uncontrolled series of 19 manic-depressive patients who had failed to respond to standard therapies, given oral methylene blue; 14 were judged to show definite improvement and 3 with an uncertain diagnosis did not respond. Study type: open case series / uncontrolled clinical report. N=19 (14 judged improved; 3 with uncertain diagnosis unresponsive). Country: UK (Dundee). Dose: not stated in the abstract (secondary sources give ~100 mg twice daily to 520 mg/day; NOT verified from primary text). Route: oral. Comparator: none. Funder/conflicts not stated in abstract. No blinding or placebo. Also filed as MTK-29 (claims C5, C7). Study type: uncontrolled series.